[unable to retrieve full-text content] Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression The New England Journal of Medicine
[unable to retrieve full-text content] Predictors of longitudinal viral load suppression among adults receiving first line antiretroviral therapy in Central Ethiopia Nature
[unable to retrieve full-text content] Why some people naturally control HIV even after stopping therapy—and how we can leverage that to treat others Medical Xpress